Literature DB >> 10983906

Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison.

D Blazer1, C Hybels, E Simonsick, J T Hanlon.   

Abstract

OBJECTIVES: Prescriptions of sedatives, hypnotics, and antianxiety medications have decreased over the past 15 years. However, racial differences have not been well investigated in controlled analyses.
DESIGN: A prospective cohort study. SETTINGS AND PARTICIPANTS: The authors analyzed data from a community-based, biracial cohort of older adults (n = 4,000 at baseline) followed for 10 years to determine sociodemographic and health characteristics associated with the use of these medications between 1986 and 1996. MAIN OUTCOME MEASURES: Information about sedative, hypnotic, and antianxiety medication use and demographic and health characteristics was obtained from a race-stratified, probability-based sample of black and white community-dwelling older adults in the Piedmont region of North Carolina during four in-person interviews spanning 10 years. Descriptive statistics were calculated. Logistic regression was used for the final models.
RESULTS: A total of 13.3% of the subjects were taking these medications in 1986, with the frequency of use declining only to 11.8% in 1996 despite the cohort aging 10 years. Correlates of use at baseline were female gender, white race, depressive symptoms, poor self-rated health, impaired physical function, and health services use. These correlates persisted for each of the three follow-up waves of the survey. In 1996, the odds for being white and using these medications was 4.70 in controlled analyses.
CONCLUSIONS: Despite the overall decline in the use of sedative, hypnotics, and antianxiety agents in the general population in recent years, over the 10 years of this survey, an aging cohort continued to use these medications at a frequency greater than the general population and did not demonstrate a significant decline in use. Factors unrelated to health status, specifically being white, were among the strongest correlates of use throughout the years of follow-up.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983906     DOI: 10.1111/j.1532-5415.2000.tb04782.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  18 in total

1.  Sleep quality in residents of assisted living facilities: effect on quality of life, functional status, and depression.

Authors:  Jennifer L Martin; Lavinia Fiorentino; Stella Jouldjian; Karen R Josephson; Cathy A Alessi
Journal:  J Am Geriatr Soc       Date:  2010-05       Impact factor: 5.562

2.  Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart.

Authors:  Tzvia Blumstein; Yael Benyamini; Angela Chetrit; Eliyahu H Mizrahi; Liat Lerner-Geva
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

3.  Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework.

Authors:  Zoi Tsimtsiou; Mark Ashworth; Roger Jones
Journal:  Br J Gen Pract       Date:  2009-06       Impact factor: 5.386

4.  Trends in use of high-risk medications for older veterans: 2004 to 2006.

Authors:  Mary Jo V Pugh; Joseph T Hanlon; Chen-Pin Wang; Todd Semla; Muriel Burk; Megan E Amuan; Ashlei Lowery; Chester B Good; Dan R Berlowitz
Journal:  J Am Geriatr Soc       Date:  2011-08-30       Impact factor: 5.562

5.  Influence of urban residence on use of psychotropic medications in Pennsylvania, USA: cross-sectional comparison of older adults attending senior centers.

Authors:  Offer Edelstein; Karen Pater; Ravi Sharma; Steven M Albert
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

6.  Sedative load among community-dwelling people aged 75 years and older: a population-based study.

Authors:  Heidi T Taipale; J Simon Bell; Maija Uusi-Kokko; Eija Lönnroos; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

7.  Benzodiazepine Use and Misuse Among Adults in the United States.

Authors:  Donovan T Maust; Lewei A Lin; Frederic C Blow
Journal:  Psychiatr Serv       Date:  2018-12-17       Impact factor: 3.084

8.  Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies.

Authors:  Marlies R de Jong; Maarten Van der Elst; Klaas A Hartholt
Journal:  Ther Adv Drug Saf       Date:  2013-08

9.  Depression in public community long-term care: implications for intervention development.

Authors:  Nancy Morrow-Howell; Enola Proctor; Sunha Choi; Lisa Lawrence; Ashley Brooks; Leslie Hasche; Peter Dore; Wayne Blinne
Journal:  J Behav Health Serv Res       Date:  2007-12-26       Impact factor: 1.505

10.  Sustained benzodiazepine use in a community sample of older adults.

Authors:  Keith R Stowell; Chung-Chou H Chang; Jonivander Bilt; Gary P Stoehr; Mary Ganguli
Journal:  J Am Geriatr Soc       Date:  2008-12       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.